Editas Medicine (EDIT) Enterprise Value (2015 - 2025)
Editas Medicine (EDIT) reported Enterprise Value of -$146.6 million for Q4 2025, up 45.67% year-over-year from -$100.7 million in Q4 2024, and up 11.47% quarter-over-quarter from -$165.6 million in Q3 2025.
Editas Medicine (EDIT) Enterprise Value (2015 - 2025) Analysis & Trends
Editas Medicine (EDIT) has 11 years of Enterprise Value data on file, last reported at -$146.6 million in Q4 2025.
- Enterprise Value for Q4 2025 came in at -$146.6 million, up 45.67% year-over-year; the trailing twelve-month figure through Dec 2025 was -$146.6 million (up 45.67% YoY), and the FY2025 annual result was -$146.6 million, up 45.67% from the prior year.
- Enterprise Value advanced to -$146.6 million in Q4 2025 per EDIT's latest filing, from -$165.6 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$146.6 million in Q4 2025 and troughed at -$625.3 million in Q1 2021.
- A 5-year average of -$362.2 million and a median of -$333.7 million in 2022 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2021 and 2025: Enterprise Value sank 50.69% in 2021, then soared 45.67% in 2025.
- A 5-year view of Enterprise Value shows it stood at -$499.8 million in 2021, then soared by 31.12% to -$344.3 million in 2022, then grew by 6.15% to -$323.1 million in 2023, then increased by 16.46% to -$269.9 million in 2024, then soared by 45.67% to -$146.6 million in 2025.
- Business Quant data shows EDIT's Enterprise Value at -$146.6 million in Q4 2025, -$165.6 million in Q3 2025, and -$178.5 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -18.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.77 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -584.73 Mn |
| 10 | Editas Medicine | 262.77 Mn | 262.77 Mn | - | -146.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -146.65 Mn |
| Sep 30, 2025 | -165.65 Mn |
| Jun 30, 2025 | -178.50 Mn |
| Mar 31, 2025 | -220.96 Mn |
| Dec 31, 2024 | -269.91 Mn |
| Sep 30, 2024 | -265.09 Mn |
| Jun 30, 2024 | -279.11 Mn |
| Mar 31, 2024 | -296.17 Mn |
| Dec 31, 2023 | -323.11 Mn |
| Sep 30, 2023 | -349.62 Mn |
| Jun 30, 2023 | -431.97 Mn |
| Mar 31, 2023 | -318.44 Mn |
| Dec 31, 2022 | -344.27 Mn |
| Sep 30, 2022 | -419.62 Mn |
| Jun 30, 2022 | -452.56 Mn |
| Mar 31, 2022 | -488.36 Mn |
| Dec 31, 2021 | -499.85 Mn |
| Sep 30, 2021 | -557.84 Mn |
| Jun 30, 2021 | -610.55 Mn |
| Mar 31, 2021 | -625.33 Mn |